Anti-Corruption, Compliance Scrutiny Increase In Emerging Markets
This article was originally published in The Pink Sheet Daily
Executive Summary
In the next few years, the Department of Justice's enforcement focus will be the Foreign Corrupt Practices Act and its application to the pharmaceutical industry, DoJ official says.